🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

China's CellX pilots lab-grown meat production, eyes U.S. market

Published 08/10/2023, 01:24 AM
Updated 08/10/2023, 03:42 AM
© Reuters. A woman tastes lab-grown meat served by CellX at an event to mark the opening of the cultivated meat company's pilot production facility in Shanghai, China August 9, 2023. REUTERS/Aly Song
ADM
-

By Casey Hall

SHANGHAI (Reuters) - In an unassuming industrial park on the outskirts of Shanghai, an unusual taste test was happening.

As part of an event on Wednesday for government, investors and media, the cultivated meat company CellX served up meat developed in a laboratory from animal cells.

The offerings included lab-grown meat kebabs and tofu with minced lab-grown meat. CellX said each dish costs less than 100 yuan ($13.87) to produce.

The company, founded in 2020, is among a handful of front runners in lab-grown meat production in China. There are also several other companies focusing on research and development.

They are part of a race globally to develop commercially viable lab-grown meat and fish products to appeal to consumers concerned about the environmental impact of livestock farming, a major source of greenhouse gas emissions.

"Our costs are at around $100 per pound, but by the time we commercially launch in two or three years, the price could go down 10 times," CellX CEO Ziliang Yang said.

The firm opened a pilot facility in Shanghai this week that Yang said can produce 'a couple of tonnes' of cultivated meat a year. The next facility, for commercial production, is expected to be constructed by 2025 and have capacity to produce hundreds of tonnes of meat a year.

Though $100 per pound marks significant progress in terms of cost from the first lab-grown hamburger, which cost $330,000 to produce in 2013, it's also a long way from the cost needed to be competitive with traditional meat products.

That needs to reach $2.92 per pound to be price competitive, according to Leticia Goncalves, president of global foods at grains merchant Archer-Daniels-Midland (NYSE:ADM), which has invested in cultivated meat companies.

With Singapore and the U.S. leading the world in terms of regulatory approvals for the retail sale of lab-grown meat products, Yang says CellX will file applications in both countries this year with the aim to start selling its products, initially in restaurants, by 2025.

China is an attractive market for cultivated meat sales given in consumes more meat than any other, reaching almost 100 million tonnes in 2021. But there is no indication when regulators might approve lab-grown meat for human consumption.

Still, the promise of China as a low-cost manufacturing base for cultivated meat is equally exciting, Yang said.

The cost of bioreactors, where the meat is grown, in China is significantly lower than in the U.S. or Europe, and the government has offered generous incentives to industry players since cultivated meat was included in the agriculture ministry's 14th five-year plan last year.

© Reuters. A woman tastes lab-grown meat served by CellX at an event to mark the opening of the cultivated meat company's pilot production facility in Shanghai, China August 9, 2023. REUTERS/Aly Song

"At the end of the day, producing in China means having that infrastructure at a relatively lower cost and this is a key advantage," Yang said. "It's really going to be about leveraging that supply chain and going overseas, that's the story as we see it."

(This story has been corrected to say lab-grown meat, not lab-grown lamb, in paragraph 3)

 

 

 
 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.